# Intas Pharmaceuticals Limited – FDA 483, Jul 31, 2017

Source: https://www.keypedia.com/records/483/intas-pharmaceuticals-limited/4f76e2d8-eaeb-4ac2-a891-807bdf0b6f08

> FDA 483 for Intas Pharmaceuticals Limited on July 31, 2017. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Intas Pharmaceuticals Limited
- Inspection Date: 2017-07-31
- Product Type: drugs
- Office Name: Office of Inspections and Investigations
- Summary: An FDA inspection of Intas Pharmaceuticals Limited in Ahmedabad, Gujarat, India, revealed a deficiency in sampling procedures for raw materials. Specifically, the firm's method for collecting composite samples from raw material containers was found to be inadequate. This indicates a potential issue with quality control and adherence to established sampling protocols.

## Related Documents

- [WARNING_LETTER - 2025-09-17](https://www.keypedia.com/records/warning_letter/intas-pharmaceuticals-limited/5823afb5-cd04-4920-9a5a-ce851b44651c) — date: September 17, 2025
- [483 - 2025-02-14](https://www.keypedia.com/records/483/intas-pharmaceuticals-limited/6c44efff-a243-4cd8-b3e1-d79aa6443242) — date: February 14, 2025
- [483 - 2024-01-24](https://www.keypedia.com/records/483/intas-pharmaceuticals-limited/6496e826-9590-4ab3-a942-cc73428a9a15) — date: January 24, 2024
- [483 - 2023-12-07](https://www.keypedia.com/records/483/intas-pharmaceuticals-limited/fb102838-718b-4e34-a970-2af5219b3940) — date: December 7, 2023
- [483 - 2023-05-12](https://www.keypedia.com/records/483/intas-pharmaceuticals-limited/439bcecd-27da-49d0-b32b-ce7d8d990792) — date: May 12, 2023

## Related Officers

- [Steven P Donald](https://www.keypedia.com/people/steven-p-donald/431cb518-7687-408b-82e4-e525a135a26b)

Company: https://www.keypedia.com/companies/intas-pharmaceuticals-limited/0db00702-d7f6-4a8b-87d1-1b32ac236cc8

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
